KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis.
KDM5B 驱动的葡萄糖代谢重编程通过乳酸/hnRNPA1 乳酸化/AR-V7 轴促进前列腺癌对恩扎卢胺的耐药性。
期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-026-02602-z
Sun Rui, Huang Yong, He Hao, Li Qiuchen, Wang Linfeng, Zhang Gaojie, Wei Ziling, Cao Yang, Li Jing, Wang Xianmin, Yang Fan, Chen Wenjun, Li Xiang, Yu Jiang, Liu Siyuan, Lei Congfeng, Jiang Yu, Peng Yueqiang, Su Huiyi, Gao Yingying, He Weiyang, Yang Lei, Liu Jiayu